Endoscopic Submucosal Dissection in the Treatment of Early Gastrointestinal Neoplasia: A UK Cohort Study to Assess Effectiveness and Safety

What this Trial Is About

Researchers are studying the use of endoscopic submucosal dissection as a treatment for early gastrointestinal neoplasia, which involves removing abnormal tissue from the digestive tract. This observational study collects data from multiple centers in the United Kingdom to assess the effectiveness and safety of this technique over time. The study aims to understand how well the procedure works in removing lesions completely and safely. Participants undergo endoscopic submucosal dissection, a procedure that uses a special endoscopic knife to remove lesions from the gastrointestinal tract in one piece. The study gathers detailed information about each patient's lesion size and location, as well as demographic details. Data on the success of complete lesion removal and any complications or adverse events are collected. During the study, researchers monitor outcomes such as curative resection rates over two years, en bloc resection rates at the time of the procedure, complication rates within 28 days after the procedure, and mortality rates over two years. Patient information and procedure details are recorded, with follow-up assessments extending up to two years to evaluate long-term results and safety.

Endoscopic Submucosal Dissection for Early GI Neoplasia in the United Kingdom